Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 09-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,856 | 18,856 | 8,265 | 5,417 | 9,455 |
| Receivables | 24,748 | 24,748 | 28,688 | 27,500 | 30,303 |
| Inventories | 33,801 | 33,801 | 32,291 | 34,596 | 39,214 |
| Other current assets | 4,385 | 4,385 | 14,979 | 14,150 | 0 |
| TOTAL | $83,928 | $83,928 | $85,677 | $84,211 | $81,858 |
| Non-Current Assets | |||||
| PPE Net | 128,575 | 128,575 | 129,006 | 128,223 | 150,576 |
| Intangibles | 18,081 | 18,081 | 18,081 | 18,081 | 18,081 |
| Other Non-Current Assets | 4,620 | 4,620 | 6,578 | 7,178 | 4,871 |
| TOTAL | $151,276 | $151,276 | $153,665 | $153,482 | $173,528 |
| Total Assets | $235,204 | $235,204 | $239,342 | $237,693 | $255,386 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 773 |
| Accounts payable and accrued liabilities | 10,115 | 10,115 | 8,220 | 7,405 | 14,967 |
| Accrued Expenses | 19,843 | 19,843 | 21,958 | 19,745 | 4,631 |
| TOTAL | $29,958 | $29,958 | $30,178 | $31,116 | $35,290 |
| Non-Current Liabilities | |||||
| Long Term Debt | 160,495 | 160,495 | 151,990 | 147,909 | 142,328 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 937 |
| Other Non-Current Liabilities | 7,965 | 7,965 | 9,741 | 11,242 | 12,576 |
| TOTAL | $168,460 | $168,460 | $161,731 | $159,151 | $160,336 |
| Total Liabilities | $198,418 | $198,418 | $191,909 | $190,267 | $195,626 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,466 | 37,466 | N/A | 37,025 | 37,025 |
| Common Shares | 37 | 37 | 37 | 37 | 37 |
| Retained earnings | -218,095 | -218,095 | -205,240 | -204,093 | -191,456 |
| Other shareholders' equity | 47,323 | 47,323 | 46,097 | 45,197 | 44,311 |
| TOTAL | $36,786 | $36,786 | $47,433 | $47,426 | $59,760 |
| Total Liabilities And Equity | $235,204 | $235,204 | $239,342 | $237,693 | $255,386 |